GENERAL27 Sept 2026
Fortis says it is ‘complete stranger’ to Daiichi-Singh Brothers dispute after SC allows forensic audit | Shares in focus | Stock Market News
Fortis Healthcare says it is a complete stranger to the Daiichi-Singh Brothers dispute, which now faces a Supreme Court-approved forensic audit. The company says it got no money from its old promoters' share sales. Fortis shares fell 4.71% to ₹836, and a market expert expects near-term pressure. If you hold the stock, expect choppy prices until clarity comes.
Key Statutory Highlights
- Fortis Healthcare told exchanges it played no part in the alleged diversion of the erstwhile promoters' shareholding.
- The Singh Brothers held under 1% and resigned from the Fortis board by March 2018, well before new investor Northern TK Venture of the IHH Healthcare group came in through a fresh share issue in November 2018.
- Fortis shares closed 4.71% lower at ₹836 on the NSE, and a market expert expects further downside pressure if the litigation stays unclear.
Actionable Advice for Taxpayers / Founders:If you hold Fortis shares, treat this as a news-driven dip rather than a confirmed loss, and wait for the company's next filing or the audit outcome before taking any buy or sell call. For your own situation, a short talk with a SEBI-registered advisor is a safer route than acting on headlines alone.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: